JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

Recruiting now · Not applicable

Conditions studied: AAA, AAA - Abdominal Aortic Aneurysm

In brief

Prospective, randomized, multi-center study designed to evaluate the outcomes of commercially available contemporary EVAR in a real-world population. Patients will be randomized into two device cohorts and compared across the primary endpoints. Patients will be followed procedurally to discharge, at 1, 6, 12 months and annually through to 5 years (total follow-up commitment).

Key facts

Study ID
NCT05064540
Run by
Endologix
People needed
450
Starts
2021-09-20
Expected to finish
2031-03-01
Last updated by the study team
2025-06-08

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.